FDA grants Pfizer's COVID-19 vaccine full approval
Health officials hope the move could help reverse the nationwide slowdown in vaccinations.
Watch CBS News
Health officials hope the move could help reverse the nationwide slowdown in vaccinations.
The Mississippi state health department said at least 70% of recent calls have been related to ingesting ivermectin.
The Food and Drug Administration has granted full approval to the COVID-19 vaccine from Pfizer and BioNTech, a move that officials hope will help boost vaccination rates and enable more companies, schools and other organizations to require the vaccine. CBS News reporter Alex Tin joins CBSN with more on the decision and the impact it's expected to have.
The FDA is aiming to fully approve the Pfizer vaccine by Monday, according to a New York Times report. Dr. Ashish Jha, dean of Brown University School of Public Health, joins “CBS This Morning” to discuss.
The company makes Sportmix and other popular brands and issued voluntary recalls in January and March linked to toxic mold and salmonella.
The Biden administration has recommended a booster shot for recipients of the Pfizer and Moderna vaccines. As David Begnaud reports, new data suggests the vaccines may be losing efficacy over time. Then, Dr. Adrian Burrowes, a family medicine physician and the CEO of Physicians Group, joins CBSN's Lana Zak to discuss the latest.
Representative Steve Scalise, the House Republican whip, says the situation in Kabul is "President Biden's Saigon moment."
A federal vaccine advisory panel meets Friday to discuss a third coronavirus vaccine dose, a day after the Food and Drug Administration authorized a booster shot for immunocompromised Americans. Dr. Bob Lahita, director of the Institute for Autoimmune and Rheumatic Diseases at St. Joseph Health, joined CBSN to discuss the changes as well as treatments for COVID-19.
The move applies to millions of Americans who are especially vulnerable because of organ transplants, certain cancers or other disorders.
The Food and Drug Administration's expected decision to authorize a third coronavirus vaccine dose comes as the White House intensifies its push to vaccinate more Americans and a growing surge in COVID-19 cases. CBS News senior White House correspondent Weijia Jiang joins CBSN to discuss this and other headlines from the administration.
Representative Marjorie Taylor Greene has once again been suspended from Twitter for sharing misinformation about COVID-19. Her account will be locked for seven days, according to Twitter.
The U.S. will require active-duty service members to be fully vaccinated against the coronavirus starting mid-September or once the vaccine receives final FDA approval. In a statement supporting the move, President Biden said being vaccinated will ensure the military force is ready to operate anywhere in the world. Weijia Jiang has more.
New York City will soon require proof of vaccination for people looking to eat inside a restaurant, use a gym or attend an indoor concert or performance. Dr. Neeta Ogden, an internal medicine specialist and immunologist, joins CBSN to discuss this upcoming mandate.
The FDA agreed that Viatris Inc.'s Semglee was interchangeable with widely used Lantus, a fast-acting insulin.
Kroger, Publix, Stop & Shop, Target and Walmart among retailers that sold spices in 32 states, Bermuda and Canada.
McCormick is recalling some of its seasonings due to possible salmonella contamination.
CBS News medical contributor Dr. David Agus weighs in on the potential need for booster shots for people over the age of 65, face mask coverings for those vaccinated, and the new projection of a deadly surge in October.
In a town hall event, President Biden shared his expectations for FDA-approved COVID vaccines and when children under the age of 12 might be cleared to get one. The CDC is also set to meet to discuss possible booster shots and the Johnson &. Johnson vaccine's efficacy. CBS News' Laura Podesta joins CBSN AM with more details.
Former FDA commissioner Scott Gottlieb said the Delta variant is "far more advanced" than other COVID-19 strains, and "for most people who get this Delta variant, it's going to be the most serious virus they get in their lifetime in terms of risk of putting them in the hospital."
The Food and Drug Administration is noting a possible increased risk of a rare neurological complication following a dose of Johnson and Johnson's coronavirus vaccine. Out of the nearly 12.8 million Americans who received the vaccine, only 100 suspected cases have been reported. CBS News correspondent Laura Podesta joins "CBSN AM" with more details.
The FDA added a warning to the Johnson & Johnson coronavirus vaccine, saying it might be linked to a small increased risk of Guillain–Barré syndrome, a rare neurological disorder. CBS News medical contributor Dr. David Agus explains.
Johnson & Johnson’s COVID-19 vaccine may be linked to about 100 cases of Guillain-Barré Syndrome, a rare autoimmune disorder that attacks the nerves, the Food and Drug Administration warned. Nikki Battiste has more.
Federal health officials flagged "a small possible risk" of developing a nervous system disorder after receiving Johnson and Johnson's COVID-19 vaccine on Monday, after the CDC identified a very rare pattern of Guillain-Barré syndrome in some recipients of the shot. As Nikki Battiste reports, there have been about 100 cases, mostly in older men. Dr. Amesh Adalja, an infectious disease expert and senior scholar at Johns Hopkins University Bloomberg School of Public Health, joins CBSN to discuss vaccine concerns and a recent spike in new infections.
Dr. Ron Elfenbein, the medical director and owner of First Call Medical Center, joins CBSN to discuss the latest on COVID-19, the risekk of the Delta variant, and whether Americans might need a booster shot in the future, as Pfizer pursues emergency use authorization for a third dose of vaccine.
The Centers for Disease Control and Prevention eased mask guidelines for fully vaccinated teachers, students and staff Friday, saying they do not need to wear masks in school buildings. Dr. William Schaffner, medical director of the National Foundation for Infectious Diseases, joined CBSN to discuss the new mask guidance and the CDC's guidance that anyone fully vaccinated does not need a COVID vaccine booster.